- 現金殖利率: 6.35%、總殖利率: 6.35%、5年平均現金配發率: 112.37%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 9.42 | 24.93 | 10.00 | 25.0 | 0.00 | 0 | 106.16 | 0.05 | 0.00 | 0 | 106.16 | 0.05 |
| 2022 (9) | 7.54 | 14.76 | 8.00 | -47.44 | 0.00 | 0 | 106.10 | -54.2 | 0.00 | 0 | 106.10 | -54.2 |
| 2021 (8) | 6.57 | -55.09 | 15.22 | 280.5 | 0.00 | 0 | 231.66 | 747.29 | 0.00 | 0 | 231.66 | 747.29 |
| 2020 (7) | 14.63 | 243.43 | 4.00 | 3.63 | 0.00 | 0 | 27.34 | -69.83 | 0.00 | 0 | 27.34 | -69.83 |
| 2019 (6) | 4.26 | 674.55 | 3.86 | -63.06 | 0.00 | 0 | 90.61 | -95.23 | 0.00 | 0 | 90.61 | -95.23 |
| 2018 (5) | 0.55 | -80.22 | 10.45 | 318.0 | 0.00 | 0 | 1900.00 | 2012.8 | 0.00 | 0 | 1900.00 | 2012.8 |
| 2017 (4) | 2.78 | -60.57 | 2.50 | -62.12 | 0.00 | 0 | 89.93 | -3.94 | 0.00 | 0 | 89.93 | -3.94 |
| 2016 (3) | 7.05 | -12.96 | 6.60 | 120.0 | 0.00 | 0 | 93.62 | 152.77 | 0.00 | 0 | 93.62 | -5.21 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 2.15 | 26.47 | -23.76 | 2.13 | 60.15 | -4.05 | 7.45 | 40.57 | 7.5 |
| 24Q2 (19) | 1.70 | -52.78 | -7.61 | 1.33 | -55.37 | -9.52 | 5.30 | 47.22 | 28.95 |
| 24Q1 (18) | 3.60 | 44.0 | 58.59 | 2.98 | 6.43 | 36.7 | 3.60 | -61.82 | 58.59 |
| 23Q4 (17) | 2.50 | -11.35 | 19.05 | 2.80 | 26.13 | 32.7 | 9.43 | 36.08 | 24.9 |
| 23Q3 (16) | 2.82 | 53.26 | 55.8 | 2.22 | 51.02 | 47.02 | 6.93 | 68.61 | 27.39 |
| 23Q2 (15) | 1.84 | -18.94 | 57.26 | 1.47 | -32.57 | 68.97 | 4.11 | 81.06 | 13.22 |
| 23Q1 (14) | 2.27 | 8.1 | -7.72 | 2.18 | 3.32 | 14.14 | 2.27 | -69.93 | -7.72 |
| 22Q4 (13) | 2.10 | 16.02 | 14.13 | 2.11 | 39.74 | 11.64 | 7.55 | 38.79 | 14.74 |
| 22Q3 (12) | 1.81 | 54.7 | -21.65 | 1.51 | 73.56 | -36.55 | 5.44 | 49.86 | 15.01 |
| 22Q2 (11) | 1.17 | -52.44 | 116.67 | 0.87 | -54.45 | 0.0 | 3.63 | 47.56 | 50.0 |
| 22Q1 (10) | 2.46 | 33.7 | 30.85 | 1.91 | 1.06 | 20.89 | 2.46 | -62.61 | 30.85 |
| 21Q4 (9) | 1.84 | -20.35 | -84.3 | 1.89 | -20.59 | 330.49 | 6.58 | 39.11 | -55.18 |
| 21Q3 (8) | 2.31 | 327.78 | 50.98 | 2.38 | 173.56 | 46.91 | 4.73 | 95.45 | 59.8 |
| 21Q2 (7) | 0.54 | -71.28 | 80.0 | 0.87 | -44.94 | 107.14 | 2.42 | 28.72 | 69.23 |
| 21Q1 (6) | 1.88 | -83.96 | 66.37 | 1.58 | 292.68 | 39.82 | 1.88 | -87.19 | 66.37 |
| 20Q4 (5) | 11.72 | 666.01 | 551.11 | -0.82 | -150.62 | -141.84 | 14.68 | 395.95 | 244.6 |
| 20Q3 (4) | 1.53 | 410.0 | 0.0 | 1.62 | 285.71 | 0.0 | 2.96 | 106.99 | 0.0 |
| 20Q2 (3) | 0.30 | -73.45 | 0.0 | 0.42 | -62.83 | 0.0 | 1.43 | 26.55 | 0.0 |
| 20Q1 (2) | 1.13 | -37.22 | 0.0 | 1.13 | -42.35 | 0.0 | 1.13 | -73.47 | 0.0 |
| 19Q4 (1) | 1.80 | 0.0 | 0.0 | 1.96 | 0.0 | 0.0 | 4.26 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 1.28 | 61.5 | 33.91 | 10.27 | 13.52 | 3.36 | N/A | - | ||
| 2024/9 | 0.79 | -38.66 | 3.59 | 8.99 | 11.11 | 3.04 | 0.68 | - | ||
| 2024/8 | 1.29 | 34.35 | 2.79 | 8.2 | 11.9 | 3.27 | 0.64 | - | ||
| 2024/7 | 0.96 | -6.07 | 0.19 | 6.91 | 13.78 | 2.71 | 0.77 | - | ||
| 2024/6 | 1.02 | 41.12 | -9.09 | 5.95 | 16.33 | 2.46 | 0.91 | - | ||
| 2024/5 | 0.72 | 1.8 | -7.41 | 4.93 | 23.49 | 2.84 | 0.79 | - | ||
| 2024/4 | 0.71 | -49.3 | 55.6 | 4.2 | 31.03 | 3.05 | 0.74 | 活動檔期帶動營收增加 | ||
| 2024/3 | 1.4 | 50.92 | 10.18 | 3.49 | 26.95 | 3.49 | 0.55 | - | ||
| 2024/2 | 0.93 | -19.75 | 40.36 | 2.09 | 41.4 | 3.08 | 0.63 | - | ||
| 2024/1 | 1.16 | 16.82 | 42.25 | 1.16 | 42.25 | 3.48 | 0.55 | - | ||
| 2023/12 | 0.99 | -25.57 | 35.71 | 11.37 | 22.69 | 3.28 | 0.58 | - | ||
| 2023/11 | 1.33 | 39.66 | 5.34 | 10.38 | 21.58 | 3.05 | 0.62 | - | ||
| 2023/10 | 0.95 | 24.93 | 20.82 | 9.05 | 24.4 | 2.97 | 0.64 | - | ||
| 2023/9 | 0.76 | -39.13 | 37.07 | 8.09 | 24.84 | 2.98 | 0.72 | - | ||
| 2023/8 | 1.26 | 30.95 | 65.38 | 7.33 | 23.69 | 3.34 | 0.64 | 因實體通路備貨 | ||
| 2023/7 | 0.96 | -14.78 | 2.63 | 6.07 | 17.56 | 2.87 | 0.74 | - | ||
| 2023/6 | 1.12 | 43.73 | 77.84 | 5.12 | 20.86 | 2.36 | 0.72 | 因新品備貨業績成長。 | ||
| 2023/5 | 0.78 | 71.1 | 26.08 | 3.99 | 10.85 | 2.51 | 0.68 | - | ||
| 2023/4 | 0.46 | -64.09 | 12.89 | 3.21 | 7.68 | 2.39 | 0.71 | - | ||
| 2023/3 | 1.27 | 92.26 | 71.78 | 2.75 | 6.86 | 2.75 | 0.47 | 因醫美節業績成長。 | ||
| 2023/2 | 0.66 | -18.66 | 0.48 | 1.48 | -19.4 | 2.21 | 0.58 | - | ||
| 2023/1 | 0.81 | 11.45 | -30.58 | 0.81 | -30.58 | 2.81 | 0.46 | - | ||
| 2022/12 | 0.73 | -42.22 | 1.42 | 9.27 | -16.2 | 2.79 | 0.41 | - | ||
| 2022/11 | 1.27 | 60.18 | 12.53 | 8.54 | -17.43 | 2.61 | 0.44 | - | ||
| 2022/10 | 0.79 | 41.73 | -32.64 | 7.27 | -21.08 | 2.11 | 0.55 | - | ||
| 2022/9 | 0.56 | -26.56 | -52.5 | 6.48 | -19.4 | 2.25 | 0.63 | 今年受大陸封城影響，營收較低。 | ||
| 2022/8 | 0.76 | -18.73 | -37.49 | 5.92 | -13.74 | 2.33 | 0.61 | - | ||
| 2022/7 | 0.93 | 47.66 | 0.73 | 5.17 | -8.64 | 2.19 | 0.64 | - | ||
| 2022/6 | 0.63 | 1.9 | -14.45 | 4.23 | -10.48 | 1.66 | 0.7 | - | ||
| 2022/5 | 0.62 | 53.19 | -18.46 | 3.6 | -9.75 | 1.77 | 0.66 | - | ||
| 2022/4 | 0.41 | -45.37 | -52.47 | 2.98 | -7.7 | 1.81 | 0.64 | 主要係受大陸及台灣疫情影響所致。 | ||
| 2022/3 | 0.74 | 12.46 | 10.64 | 2.57 | 8.36 | 2.57 | 0.38 | - | ||
| 2022/2 | 0.66 | -43.81 | -14.71 | 1.83 | 7.46 | 2.55 | 0.39 | - | ||
| 2022/1 | 1.17 | 62.84 | 25.85 | 1.17 | 25.85 | 3.02 | 0.33 | - | ||
| 2021/12 | 0.72 | -35.9 | 15.93 | 11.06 | 44.64 | 3.02 | 0.38 | - | ||
| 2021/11 | 1.12 | -4.13 | 36.43 | 10.34 | 47.18 | 3.47 | 0.33 | - | ||
| 2021/10 | 1.17 | -0.06 | 80.47 | 9.22 | 48.61 | 3.56 | 0.32 | 本月線上通路銷售持續上升及大陸因應促銷活動提前備貨。 | ||
| 2021/9 | 1.17 | -3.35 | 54.66 | 8.04 | 44.88 | 3.31 | 0.43 | 本月線上通路銷售持續上升及大陸因應促銷活動提前備貨。 | ||
| 2021/8 | 1.21 | 30.98 | 62.1 | 6.87 | 43.33 | 2.88 | 0.5 | 疫情趨緩實體通路銷售回升及大陸因應促銷活動提前備貨。 | ||
| 2021/7 | 0.93 | 25.4 | 15.46 | 5.66 | 39.86 | 2.43 | 0.59 | - | ||
| 2021/6 | 0.74 | -2.87 | 12.42 | 4.73 | 45.9 | 2.35 | 0.56 | - | ||
| 2021/5 | 0.76 | -10.71 | 89.7 | 3.99 | 54.42 | 2.28 | 0.57 | 去年同期受疫情影響，營收基期較低。 | ||
| 2021/4 | 0.85 | 27.19 | 145.1 | 3.23 | 47.93 | 2.3 | 0.57 | 去年同期受疫情影響，營收基期較低。 | ||
| 2021/3 | 0.67 | -13.31 | -15.71 | 2.38 | 29.51 | 2.38 | 0.54 | - | ||
| 2021/2 | 0.77 | -17.08 | 125.97 | 1.71 | 64.11 | 2.33 | 0.55 | 去年同期受疫情影響，營收基期較低。 | ||
| 2021/1 | 0.93 | 50.01 | 33.75 | 0.93 | 33.75 | 2.38 | 0.54 | - | ||
| 2020/12 | 0.62 | -24.56 | 3.56 | 7.65 | -24.6 | 2.1 | 0.49 | - | ||
| 2020/11 | 0.82 | 26.81 | -2.8 | 7.02 | -26.38 | 2.23 | 0.46 | - | ||
| 2020/10 | 0.65 | -14.35 | -28.88 | 6.2 | -28.67 | 2.16 | 0.48 | - | ||
| 2020/9 | 0.76 | 1.29 | 20.04 | 5.55 | -28.65 | 2.31 | 0.57 | - | ||
| 2020/8 | 0.75 | -6.69 | -28.73 | 4.79 | -32.96 | 2.21 | 0.59 | - | ||
| 2020/7 | 0.8 | 22.09 | -17.33 | 4.04 | -33.68 | 1.86 | 0.7 | - | ||
| 2020/6 | 0.66 | 63.89 | -15.87 | 3.24 | -36.78 | 1.41 | 0.98 | - | ||
| 2020/5 | 0.4 | 15.35 | -53.35 | 2.58 | -40.54 | 1.54 | 0.89 | 因大陸轉投資公司不再併入合併報表及新冠肺炎疫情影響銷售所致。 | ||
| 2020/4 | 0.35 | -56.25 | -61.43 | 2.18 | -37.38 | 1.48 | 0.93 | 因大陸轉投資公司不再併入合併報表及新冠肺炎疫情影響銷售所致。 | ||
| 2020/3 | 0.8 | 132.39 | -13.53 | 1.83 | -28.99 | 1.83 | 0.7 | - | ||
| 2020/2 | 0.34 | -50.92 | -49.1 | 1.04 | -37.53 | 1.64 | 0.79 | - | ||
| 2020/1 | 0.7 | 16.15 | -29.69 | 0.7 | -29.69 | 2.14 | 0.6 | - | ||
| 2019/12 | 0.6 | -29.21 | -6.96 | 10.14 | 5.31 | 0.0 | N/A | - | ||
| 2019/11 | 0.85 | -7.21 | -36.63 | 9.54 | 6.19 | 0.0 | N/A | - |
